PH

Padmin Hasitkant Buch

Active Director Director DIN 03411816
DIN 03411816 First appointment Feb 2011 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 3 active board seats
Past companies 3 historical roles
Total affiliations 6 Since Feb 2011
Shareholding value •••• Premium profile

About Padmin Hasitkant Buch

Data last updated:

Padmin Hasitkant Buch is a Director at Troikaa Pharmaceuticals Limited (since 2016), Director at Bhagwati Spherocast Private Limited (since 2024) and Director at Troikaa Pharmachem Private Limited (since 2021). The companies operate in Pharma, Manufacturing and Machinery and Equipment. The 3 current companies with reported revenue have a combined latest revenue of ₹1,323 Cr; the largest is Troikaa Pharmaceuticals Limited at ₹1,088 Cr (FY 2025). Earlier, Padmin Hasitkant Buch was a Director at Shilp Gravures Limited (2020–2025) and Director at Bhagwati Autocast Limited (2011–2024) and 1 more.

DIN 03411816
Primary Designation Director
Industry Pharma
First Appointment 04 Feb 2011
Oldest Company Age 50 yrs
Largest company Troikaa Pharmaceuticals Limited · ₹1,088 Cr (FY 2025)
Combined revenue ₹1,323 Cr across 3 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Troikaa Pharmaceuticals Limited U24100GJ1994PLC022162
Director02 May 20161994₹1,088 Cr (FY 2025)Active
Bhagwati Spherocast Private Limited U27310GJ1976PTC002926
Director28 Sep 20241976₹232 Cr (FY 2025)Active
Troikaa Pharmachem Private Limited U24299GJ2021PTC127098
Director08 Nov 20212021₹2.57 Cr (FY 2025)Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Shilp Gravures Limited L27100GJ1993PLC020552
Director31 Jan 20201993₹94.69 Cr (FY 2025)Active
Bhagwati Autocast Limited L27100GJ1981PLC004718
Director04 Feb 20111981₹141 Cr (FY 2025)Active
Troikaa Pharmaceuticals Limited U24231GJ1999PLC035441
Director04 Sep 20141999Amalgamated

Explore Director's current and past company associations Uncover their professional journey today!

Board colleagues of Padmin Hasitkant Buch

NameDINCompanyDesignation
Achyutkumar Dadubhai Patel02115679Troikaa Pharmaceuticals Limited , Troikaa Pharmachem Private LimitedWhole-Time Director
Asheel Ketan Patel08815072Troikaa Pharmaceuticals Limited , Troikaa Pharmachem Private LimitedWhole-Time Director
Bhavin SanghaviTroikaa Pharmaceuticals LimitedCfo
Binita Milan Patel00187286Troikaa Pharmaceuticals Limited , Troikaa Pharmachem Private LimitedWhole-Time Director
Chandrakant Kantilal Thakkar02860342Troikaa Pharmaceuticals LimitedAdditional Director
Ketan Rajnikant Patel00187213Troikaa Pharmaceuticals Limited , Troikaa Pharmachem Private LimitedManaging Director
Kush Milan Patel08815083Troikaa Pharmaceuticals Limited , Troikaa Pharmachem Private LimitedWhole-Time Director
Milan Rajnikant Patel00187237Troikaa Pharmaceuticals Limited , Troikaa Pharmachem Private LimitedManaging Director
Nisheel Ketan Patel10085228Troikaa Pharmaceuticals Limited , Troikaa Pharmachem Private LimitedWhole-Time Director
Prakash Jayantilal Shah02130088Troikaa Pharmaceuticals LimitedDirector
Shivangi GajjarTroikaa Pharmaceuticals LimitedCompany Secretary
Subir Kumar Das02237356Troikaa Pharmaceuticals Limited , Troikaa Pharmachem Private LimitedDirector
Sushma Ketan Patel00187264Troikaa Pharmaceuticals Limited , Troikaa Pharmachem Private LimitedWhole-Time Director
Jagat Jayant Shah00198802Bhagwati Spherocast Private LimitedDirector
Pravin Natvarlal Bhagwati00096799Bhagwati Spherocast Private LimitedManaging Director
Reena Bhagwati Pravin00096280Bhagwati Spherocast Private LimitedDirector
Shivangi Gajjar07243790Troikaa Pharmachem Private LimitedCompany Secretary

Directorship timeline

Open interactive timeline →
Troikaa Pharmaceuticals Limited
Troikaa Pharmachem Private Limited
Troikaa Pharmaceuticals Limited
Bhagwati Spherocast Private Limited
Premium access

Shareholding and investment profile for Padmin Hasitkant Buch

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Padmin Hasitkant Buch

Padmin Hasitkant Buch currently holds 3 directorships: Troikaa Pharmaceuticals Limited (Director, since 02 May 2016, revenue ₹1,088 Cr (FY 2025)); Bhagwati Spherocast Private Limited (Director, since 28 Sep 2024, revenue ₹232 Cr (FY 2025)); Troikaa Pharmachem Private Limited (Director, since 08 Nov 2021, revenue ₹2.57 Cr (FY 2025)).

Padmin Hasitkant Buch was first appointed on 04 Feb 2011 as Director at Bhagwati Autocast Limited. The most recent appointment on record is 28 Sep 2024 at Bhagwati Spherocast Private Limited.

The 3 current companies of Padmin Hasitkant Buch that report revenue have a combined latest revenue of ₹1,323 Cr: Troikaa Pharmaceuticals Limited ₹1,088 Cr (FY 2025); Bhagwati Spherocast Private Limited ₹232 Cr (FY 2025); Troikaa Pharmachem Private Limited ₹2.57 Cr (FY 2025).

Padmin Hasitkant Buch held 3 earlier board appointments: Shilp Gravures Limited (Director, 31 Jan 2020 to 30 Jan 2025); Bhagwati Autocast Limited (Director, 04 Feb 2011 to 23 Sep 2024); Troikaa Pharmaceuticals Limited (Director, from 04 Sep 2014).

The current boards of Padmin Hasitkant Buch's companies include Achyutkumar Dadubhai Patel (Troikaa Pharmaceuticals Limited), Asheel Ketan Patel (Troikaa Pharmaceuticals Limited), Bhavin Sanghavi (Troikaa Pharmaceuticals Limited), Binita Milan Patel (Troikaa Pharmaceuticals Limited), Chandrakant Kantilal Thakkar (Troikaa Pharmaceuticals Limited), Ketan Rajnikant Patel (Troikaa Pharmaceuticals Limited), among others.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available